Luca De Maso
Trieste, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
DNA-loaded targeted nanoparticles as a safe platform to produce exogenous proteins in tumor B cells.
DNA-loaded targeted nanoparticles as a safe platform to produce exogenous proteins in tumor B cells.
Journal: Frontiers in immunology
Published: October 10, 2024
Stealth-Engineered Albumin-Coated Nanoparticles for Targeted Therapy: Effective Drug Delivery and Tumor Suppression in Xenograft-Zebrafish Model.
Journal: International journal of nanomedicine
Published: July 12, 2024
Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticles.
Journal: Journal of nanobiotechnology
Published: July 24, 2023
Zebrafish: A Useful Animal Model for the Characterization of Drug-Loaded Polymeric NPs.
Journal: Biomedicines
Published: August 19, 2022
Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination.
Journal: Journal of autoimmunity
Published: August 19, 2021
Multiple-Organ Complement Deposition on Vascular Endothelium in COVID-19 Patients.
Journal: Biomedicines
Published: June 29, 2021
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis.
Journal: Journal of autoimmunity
Published: February 21, 2019
Invasive meningococcal disease in three siblings with hereditary deficiency of the 8(th) component of complement: evidence for the importance of an early diagnosis.
Journal: Orphanet journal of rare diseases
Published: January 15, 2016
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice.
Journal: Leukemia
Published: February 21, 2014
Last Updated: 09/26/2026